Strategic Information for the Life Science and Analytical Instrument Industry
FY19 Corporate R&D Spending Grows Close to 10%
New Funding Commitments Announced
News from Cytiva, Microsaic, etc.
Fourth Quarter 2020 Results: Bio-Techne, Biotage, Fluidigm and Illumina
Surface Plasmon Resonance Analyzers
Biopharmaceutical
Academia
Clinical
Japan
EU
UK
Life Science Consumables
MS & LC/MS
Chromatography
Sample Preparation
BioProcess International US West to Present Latest Developments in Bioprocessing
February 26, 2021 5:21 pm
The Molecular Point-of-Care Market Expected to Have a Bumpy Ride
February 11, 2021 4:15 pm
Danaher’s SCIEX and Molecular Devices Businesses Debut New Products
February 3, 2021 7:19 pm
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Learn moreOKWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refuseing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.
If you do not want that we track your visist to our site you can disable tracking in your browser here:
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Vimeo and Youtube video embeds:
BioProcess International US West to Present Latest Developments in Bioprocessing
The annual BioProcess International US West Conference & Exhibition will be held March 29–30 virtually. The conference consists of six tracks: Cell Line Development & Engineering; Cell Culture; Recovery & Purification; Manufacturing Strategy & Bioprocessing 4.0; Intensified & Continuous Processing; Cell & Gene Therapies; and the 4th Annual BioInnovation Group Technology Session. BioProcess International US […]
The Molecular Point-of-Care Market Expected to Have a Bumpy Ride
The advent of the COVID-19 pandemic in 2020 has made the need for molecular point-of-care (mPOC) technologies, such as testing for strep throat, HPV, tuberculosis and more, have further driven demand from the clinical and medical sectors. As a result, more companies are offering related products to fulfill end-user demand. In January 2021, Kalorama Information […]
Danaher’s SCIEX and Molecular Devices Businesses Debut New Products
It has been a busy beginning of the year for Danaher’s Life Sciences segment. In January, the business reported 2020 revenues of $10.6 billion, representing 47% of the total revenues of science and technology conglomerate Danaher. The Life Sciences unit such as biopharmaceuticals and COVID-19 vaccines. In 2020, the pharmaceutical end-market represented approximately 25% of […]
Biden Administration Backs Science
Early signs from the Biden Administration indicate the Administration is elevating the role of science in its policymaking and actions. President Biden has already promoted the role of science advisor and director of the Office of Science and Technology policy to the level of a Cabinet position. Made up of 25 members, Cabinet members serve […]
Market Demand in the Single-Cell Genomics Sector Expected to Rise
The single-cell genomics discipline has become an essential component of biological research. These technologies are playing key roles in various scientific fields such as infections disease treatments, cancer research and neurological studies. As a result, more companies are offering related products to fulfill end-user demand. In December 2020, Kalorama Information released its “ Single-Cell Genomics […]